Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

10.8%

4 terminated/withdrawn out of 37 trials

Success Rate

87.9%

+1.4% vs industry average

Late-Stage Pipeline

76%

28 trials in Phase 3/4

Results Transparency

7%

2 of 29 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
14(40.0%)
Phase 3
14(40.0%)
Phase 2
5(14.3%)
N/A
2(5.7%)
35Total
Phase 4(14)
Phase 3(14)
Phase 2(5)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials
NCT00176423Phase 4Completed

Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

Role: collaborator

NCT00257010Phase 3Completed

A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

Role: collaborator

NCT00369603Phase 4Terminated

Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

Role: collaborator

NCT00283725Completed

Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease

Role: lead

NCT00131443Phase 2Completed

Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine

Role: collaborator

NCT00280839Phase 3Completed

Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation

Role: collaborator

NCT00210912Phase 3Completed

A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Role: collaborator

NCT00236496Phase 3Completed

A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.

Role: collaborator

NCT00210574Phase 2Completed

A Pilot Study of Topiramate in Childhood Absence Epilepsy

Role: collaborator

NCT00210873Phase 3Completed

An Open Label Extension of a Study of Topiramate in Chronic Migraine.

Role: collaborator

NCT00210808Phase 2Completed

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity

Role: collaborator

NCT00210782Phase 3Completed

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Role: collaborator

NCT00210821Phase 3Completed

Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches

Role: collaborator

NCT00266604Phase 4Completed

A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Role: collaborator

NCT00210860Phase 3Completed

An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.

Role: collaborator

NCT00035204Phase 4Completed

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Role: collaborator

NCT00082602Phase 3Completed

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

Role: collaborator

NCT00237289Phase 3Completed

Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting

Role: lead

NCT00212823Phase 4Completed

The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain

Role: lead

NCT00212810Phase 4Completed

Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.

Role: lead